Fundamental Valuation Report bluebird bio(BLUE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$131.32 (USD) 22/02/2019 Weighted Valuation$154.06 (USD) Overall RatingUndervalued by 17.3% Valuation Models Analyst Consensus: $150.00 (USD) (in …
bluebird bio (BLUE:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.53 (USD) 18/01/2019 Weighted Valuation$23.36 (USD) Overall RatingUndervalued by 33.2% Valuation Models Analyst Consensus: $30.00 (USD) (in …
Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.70 (USD) 24/10/2018 Weighted Valuation$22.50 (USD) Overall RatingUndervalued by 64.3% Valuation Models Analyst Consensus: $26.00 (USD) (in …
Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »
Read MorePrint This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all …
Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »
Read More